Literature DB >> 16200214

Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo.

YuZhen Zhang1, Jaqueline R Da Silva, Muredach Reilly, Jeffrey T Billheimer, George H Rothblat, Daniel J Rader.   

Abstract

Hepatic expression of the scavenger receptor class B type I (SR-BI) promotes selective uptake of HDL cholesterol by the liver and is believed to play a role in the process of reverse cholesterol transport (RCT). We hypothesized that hepatic SR-BI expression is a regulator of the rate of integrated macrophage-to-feces RCT and used an in vivo model to test this hypothesis. Cholesterol-loaded and [3H]cholesterol-labeled J774 macrophages were injected intraperitoneally into mice, after which the appearance of the [3H]cholesterol in the plasma, liver, and feces over 48 hours was quantitated. Mice overexpressing SR-BI in the liver had significantly reduced [3H]cholesterol in the plasma but markedly increased [3H] tracer excretion in the feces over 48 hours. Conversely, mice deficient in SR-BI had significantly increased [3H]cholesterol in the plasma but markedly reduced [3H] tracer excretion in the feces over 48 hours. These studies demonstrate that hepatic SR-BI expression, despite its inverse effects on steady-state plasma HDL cholesterol concentrations, is an important positive regulator of the rate of macrophage RCT.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16200214      PMCID: PMC1236682          DOI: 10.1172/JCI25327

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

1.  Differentiation-dependent expression and localization of the class B type I scavenger receptor in intestine.

Authors:  S F Cai; R J Kirby; P N Howles; D Y Hui
Journal:  J Lipid Res       Date:  2001-06       Impact factor: 5.922

2.  Effect of up-regulating individual steps in the reverse cholesterol transport pathway on reverse cholesterol transport in normolipidemic mice.

Authors:  K Alam; R S Meidell; D K Spady
Journal:  J Biol Chem       Date:  2001-02-20       Impact factor: 5.157

3.  Hepatic scavenger receptor BI promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bile.

Authors:  Y Ji; N Wang; R Ramakrishnan; E Sehayek; D Huszar; J L Breslow; A R Tall
Journal:  J Biol Chem       Date:  1999-11-19       Impact factor: 5.157

4.  Down-regulation of intestinal scavenger receptor class B, type I (SR-BI) expression in rodents under conditions of deficient bile delivery to the intestine.

Authors:  P J Voshol; M Schwarz; A Rigotti; M Krieger; A K Groen; F Kuipers
Journal:  Biochem J       Date:  2001-06-01       Impact factor: 3.857

5.  Role of scavenger receptors SR-BI and CD36 in selective sterol uptake in the small intestine.

Authors:  M Werder; C H Han; E Wehrli; D Bimmler; G Schulthess; H Hauser
Journal:  Biochemistry       Date:  2001-09-25       Impact factor: 3.162

6.  Hepatic cholesterol and bile acid metabolism and intestinal cholesterol absorption in scavenger receptor class B type I-deficient mice.

Authors:  P Mardones; V Quiñones; L Amigo; M Moreno; J F Miquel; M Schwarz; H E Miettinen; B Trigatti; M Krieger; S VanPatten; D E Cohen; A Rigotti
Journal:  J Lipid Res       Date:  2001-02       Impact factor: 5.922

Review 7.  New insights into the regulation of HDL metabolism and reverse cholesterol transport.

Authors:  Gary F Lewis; Daniel J Rader
Journal:  Circ Res       Date:  2005-06-24       Impact factor: 17.367

8.  Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice.

Authors:  Anne Braun; Bernardo L Trigatti; Mark J Post; Kaori Sato; Michael Simons; Jay M Edelberg; Robert D Rosenberg; Mark Schrenzel; Monty Krieger
Journal:  Circ Res       Date:  2002-02-22       Impact factor: 17.367

9.  Relationship between expression levels and atherogenesis in scavenger receptor class B, type I transgenics.

Authors:  Y Ueda; E Gong; L Royer; P N Cooper; O L Francone; E M Rubin
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

10.  Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse.

Authors:  K F Kozarsky; M H Donahee; J M Glick; M Krieger; D J Rader
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-03       Impact factor: 8.311

View more
  124 in total

Review 1.  Genetics of cholesterol efflux.

Authors:  Iulia Iatan; Aurélien Palmyre; Sarah Alrasheed; Isabelle Ruel; Jacques Genest
Journal:  Curr Atheroscler Rep       Date:  2012-06       Impact factor: 5.113

2.  Cholesterol Efflux Capacity and Subclasses of HDL Particles in Healthy Women Transitioning Through Menopause.

Authors:  Samar R El Khoudary; Patrick M Hutchins; Karen A Matthews; Maria M Brooks; Trevor J Orchard; Graziella E Ronsein; Jay W Heinecke
Journal:  J Clin Endocrinol Metab       Date:  2016-07-11       Impact factor: 5.958

Review 3.  Therapies targeting exogenous cholesterol uptake: new insights and controversies.

Authors:  Michael H Davidson
Journal:  Curr Atheroscler Rep       Date:  2011-02       Impact factor: 5.113

Review 4.  Molecular regulation of HDL metabolism and function: implications for novel therapies.

Authors:  Daniel J Rader
Journal:  J Clin Invest       Date:  2006-12       Impact factor: 14.808

5.  Plasma-advanced oxidation protein products are potent high-density lipoprotein receptor antagonists in vivo.

Authors:  Gunther Marsche; Sasa Frank; Andelko Hrzenjak; Michael Holzer; Sabine Dirnberger; Christian Wadsack; Hubert Scharnagl; Tatjana Stojakovic; Akos Heinemann; Karl Oettl
Journal:  Circ Res       Date:  2009-01-29       Impact factor: 17.367

6.  Obesity-associated improvements in metabolic profile through expansion of adipose tissue.

Authors:  Ja-Young Kim; Esther van de Wall; Mathieu Laplante; Anthony Azzara; Maria E Trujillo; Susanna M Hofmann; Todd Schraw; Jorge L Durand; Hua Li; Guangyu Li; Linda A Jelicks; Mark F Mehler; David Y Hui; Yves Deshaies; Gerald I Shulman; Gary J Schwartz; Philipp E Scherer
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

Review 7.  Scavenger receptor B type 1: expression, molecular regulation, and cholesterol transport function.

Authors:  Wen-Jun Shen; Shailendra Asthana; Fredric B Kraemer; Salman Azhar
Journal:  J Lipid Res       Date:  2018-05-02       Impact factor: 5.922

Review 8.  Mendelian randomization in cardiometabolic disease: challenges in evaluating causality.

Authors:  Michael V Holmes; Mika Ala-Korpela; George Davey Smith
Journal:  Nat Rev Cardiol       Date:  2017-06-01       Impact factor: 32.419

9.  Pathways by which reconstituted high-density lipoprotein mobilizes free cholesterol from whole body and from macrophages.

Authors:  Marina Cuchel; Sissel Lund-Katz; Margarita de la Llera-Moya; John S Millar; David Chang; Ilia Fuki; George H Rothblat; Michael C Phillips; Daniel J Rader
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-12-17       Impact factor: 8.311

10.  Effects of nevirapine and efavirenz on HDL cholesterol levels and reverse cholesterol transport in mice.

Authors:  Junichiro Tohyama; Jeffrey T Billheimer; Ilia V Fuki; George H Rothblat; Daniel J Rader; John S Millar
Journal:  Atherosclerosis       Date:  2008-09-27       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.